Bank of Montreal’s Treace Medical Concepts TMCI Stock Holding History

Bank of Montreal’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300,000	Closed	-$7.36M	–	4181
2022 Q4	$7.36M	Buy	300,000 +148,000	+97%	+$3.41M	﹤0.01%	1110
2022 Q3	$3.5K	Sell	152,000 -16,000	-10%	-$310K	﹤0.01%	1539
2022 Q2	$2.58K	Buy	+168,000	New	+$2.83M	﹤0.01%	1768

Other funds holding TMCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of Montreal's TMCI Position: Q4 2022 in Review

Bank of Montreal sold out of Treace Medical Concepts (TMCI) in Q4 2022, closing a stake of 2,373 shares — an estimated $54.6K sold.

Bank of Montreal first reported a position in TMCI in Q2 2022 and held it in 2 quarters. The position peaked at $54 in Q3 2022. 106 funds tracked by Wall St. Rank hold TMCI as of Q4 2022.

Bank of Montreal reported no remaining Treace Medical Concepts position as of Q4 2022 after selling out during the quarter.
Bank of Montreal sold 2,373 Treace Medical Concepts shares in Q4 2022, an estimated $54.6K.
Bank of Montreal first reported a position in Treace Medical Concepts in Q2 2022 and held it in 2 quarters.
Bank of Montreal's Treace Medical Concepts position peaked at $54 in Q3 2022.
106 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.